One of the most powerful assets in improving patient safety is the expanding quantity of product related data across the development life cycle. However, Pharmacovigilance organizations may have trouble tapping into this wealth of knowledge because of the fragmented, isolated data, and siloed technologies. What is needed is a solution that integrates technologies, processes, and talent—plus traditional and “real world” data sources—to detect, assess, understand, and help prevent safety-related issues while uncovering benefits that can improve patient outcomes. Organizations that are consolidating their fragmented systems and data on a scalable, evidence- based analytic platform that enables them to be compliant, consistent, and efficient while gaining advantage from previously hidden insights.
Join Deloitte leaders as they discuss the evolving safety space and the imperative for a data driven safety strategy.